Starhao Pharmaceutical

Beijing Starhao Pharmaceutical, a subsidiary of Sihuan Pharmaceutical Holdings, is a China-based pharmaceutical company focused on the research, development, and manufacturing of high-quality finished drug products and active pharmaceutical ingredients (APIs). The company maintains advanced manufacturing facilities that comply with EU-GMP and China GMP standards, specializing in high-barrier generic drugs and innovative formulations. Its portfolio spans multiple therapeutic areas, including cardiovascular disease, central nervous system disorders, and anti-infectives. Starhao is recognized for its strong R&D capabilities and international market expansion, particularly in the production of complex small-molecule drugs like carbapenem antibiotics. The company serves as a key high-end manufacturing hub for its parent group's internationalization strategy.